Author: Maria Alejandra Gomez Rocha (Colombia)
Co-authors: Luz Martinez Malo, Carlos Mario Rangel, Laura Catalina Leal Forero
Purpose
To evaluate demographic characteristics, clinical features, systemic disease associations and visual outcomes of patients Scleritis in a Colombian tertiary care referral center.
Setting/Venue
Medical records of patients who were diagnosed with scleritis At the Ocular uveitis service in Fundación Oftalmológica de Santander Carlos Ardila Lule (FOSCAL) a tertiary eye care center in Floridablanca, Santander, Colombia were reviewed.
Methods
Data from 48 patients with scleritis followed from 2015 to 2020 were retrospectively evaluated. The main outcome measures were demographics, ocular disease characteristics and complications, presence of systemic associated disease and treatment regimen.
Results
In a series of 48 patients, women were overrepresented among scleritis patients with a relation of 2.4 : 1 corresponding to a 70.8% (n=34). Scleritis were found bilaterally in 20.8% (n=10) of patients. Scleritis was diffuse in 19, nodular in 21, necrotizing in 2, and posterior in 4 patients. Anterior uveitis (37%; n=17), Panuveitis (4.3%; n=2), ocular hypertension (4.3%; n=2), Macular Edema (2.3%; n=1) and Peripheral ulcerative keratitis (6.5%; n=3) were encountered as ocular complications in patients with scleritis. An associated systemic disease was found in 25% of patients with scleritis among which Rheumatoid Arthritis was the most prevalent systemic disease (72% n=8). 13.3% (n=6) of patients with scleritis required Intravenous corticosteroids, 35.6%(n=16) oral corticosteroids, 20% (n=9) immunosuppressive drugs, and 6.6% (n=3) Biologic medication.
Conlusions
Scleritis is a vision-threatening condition that requires prompt diagnosis, systemic assessment, and accurate treatment in order to prevent ocular and systemic complications. This study provides an insight about the scleritis distribution and characterization, ocular complications and associated diseases in a Latin American population. To our knowledge this is the first study that presents information of this entity in our population.
Financial Disclosure
We have no financial relations or interests
Comments
-